Thus, in the case of the breast cancer patient with quasi-mesenchymal cells in the CTC isolates, we were able to establish long term cultures and demonstrate a very significant expansion of the number of the HER2 positive cells. The gene discussed is ERBB2; the disease is breast carcinoma.